Sera Prognostics Inc

NASDAQ SERA

Data sourced from

and

Daily

Download Data

Sera Prognostics Inc Price to Earnings Ratio (P/E) on June 03, 2024: -26.93

Sera Prognostics Inc Price to Earnings Ratio (P/E) is -26.93 on June 03, 2024, a -1,057.86% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.

Sera Prognostics Inc 52-week high Price to Earnings Ratio (P/E) is -1.16 on September 08, 2023, which is 95.70% above the current Price to Earnings Ratio (P/E).
Sera Prognostics Inc 52-week low Price to Earnings Ratio (P/E) is -29.80 on May 06, 2024, which is -10.67% below the current Price to Earnings Ratio (P/E).
Sera Prognostics Inc average Price to Earnings Ratio (P/E) for the last 52 weeks is -7.14.

NASDAQ: SERA

Sera Prognostics Inc

CEO	Dr. Gregory C. Critchfield M.D., M.S.
IPO Date	July 15, 2021
Location	United States
Headquarters	2749 East Parleys Way, Salt Lake City, UT, United States, 84109
Employees	55
Sector	Healthcare
Industry	Diagnostics & research

Description

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Key trends